On June 11, 2025, the US Food and Drug Administration (FDA) released educational materials to broaden dietary supplement manufacturers’ ...

On April 22, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) announced a plan to phase ...

An FDA panel meeting featured a heated dialogue over whether fluoride supplements could pose health risks to children. Here's ...

Explore the FDA’s 2025 Human Foods Program Guidance Agenda and what it means for US food and beverage businesses. Key ...

The Boston-based digital pathology firm's updated US Food and Drug Administration clearance will help it to quickly validate its software with new hardware combinations.

Vitamins? Minerals? Botanicals? Extracts? Choosing the right supplements can be confusing. An expert offers five tips to help ...

The Utah Dental Association (UDA) is urging the public to submit comments to the U.S. Food and Drug Administration (FDA) in support of ingestible fluoride supplements.

The Utah Dental Association (UDA) urges the public and members of the dental and healthcare communities to submit comments to the U.S. Food and Drug Administration (FDA) in support of maintaining ...

Capricor Therapeutics shares plummeted in premarket trading Friday after the U.S. Food and Drug Administration turned away the biotechnology company's bid for approval of Deramiocel, its lead cell ...

Informed by the FDA meeting, Milestone submitted the response to the CRL on June 13, 2025. Included in that response were the results of additional in-vitro studies conducted to meet the updated FDA ...

Milestone Pharmaceuticals announces FDA's new review date for CARDAMYST and extends a $75 million royalty agreement with RTW.

Included in that response were the results of additional in-vitro studies conducted to meet the updated FDA guidance on nitrosamines, which had been updated since the original NDA submission.